Acting as GLP-1R agonists (GLP-1RAs), the drugs promote feelings of satiety and fullness, aiding weight loss among patients who are overweight or obese. Aside from their success for type 2 diabetes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback